| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |